Maternal plasma DNA testing: Experience of women counseled at a prenatal diagnosis center

Genetic Testing and Molecular Biomarkers

Volumn 18, Issue 10, 2014, Pages 665-669

  O'Brien, Barbara M ^a   Kloza, Edward M ^a   Halliday, Jacquelyn V ^a   Lambert Messerlian, Geralyn M ^a   Palomaki, Glenn E ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ANEUPLOIDY; ARTICLE; AWARENESS; CONTROLLED STUDY; DIAGNOSTIC REASONING; ECHOGRAPHY; FEMALE; FOLLOW UP; GENETIC COUNSELING; GENETIC SCREENING; HIGH RISK PATIENT; HUMAN; INSURANCE; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL PLASMA; MEDICAL RECORD REVIEW; PATIENT DECISION MAKING; PRENATAL DIAGNOSIS; BLOOD; PREGNANCY;

DNA; FEMALE; GENETIC COUNSELING; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84907479779     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2014.0125     Document Type: Article

References (9)

1. ACOG (2007) ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol 110:1459-1467.
2. ACOG (2012) Noninvasive prenatal testing for fetal aneuploidy. Committee Opinion No. 545: American College of Obstetricians and Gynecologists. Obstet Gynecol 120:1532-1534.
3. Carroll FE, Al-Janabi H, Flynn T, et al. (2013) Women and their partners' preferences for Down's syndrome screening tests: a discrete choice experiment. Prenat Diagn 33:449-456.
4. Chetty S, Garabedian MJ, Norton ME (2013) Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenat Diagn 33:542-546.
5. Hill M, Fisher J, Chitty LS, et al. (2012) Women's and health professionals' preferences for prenatal tests for Down syndrome: a discrete choice experiment to contrast noninvasive prenatal diagnosis with current invasive tests. Genet Med 14:905-913.
6. Palomaki GE, Deciu C, Kloza EM, et al. (2012) DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 14:296-305.
7. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. (2011) DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 13:913-920.
8. Taylor J B, Chock VY, Hudgins L (2014) NIPT in a clinical setting: an analysis of uptake in the first months of clinical availability. J Genet Couns 23:72-78.
9. Vahanian SA, Baraa Allaf M, Yeh C, et al. (2014) Patient acceptance of non-invasive testing for fetal aneuploidy via cellfree fetal DNA. J Matern Fetal Neonatal Med 27:106-109.